Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer.
about
Chemically modified non-antimicrobial tetracyclines are multifunctional drugs against advanced cancersThe evolving role of zoledronic acid in early breast cancerAnti-tumour activity of bisphosphonates in preclinical models of breast cancer.Breast cancer cells induce osteolytic bone lesions in vivo through a reduction in osteoblast activity in mice.Doxycycline Promotes Carcinogenesis & Metastasis via Chronic Inflammatory Pathway: An In Vivo ApproachThe impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis.A cell-delivered and cell-activated SN38-dextran prodrug increases survival in a murine disseminated pancreatic cancer modelPeriodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat.Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone.CCN1, a candidate target for zoledronic acid treatment in breast cancer.A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancer.Strategies for obtaining bone biopsy specimens from breast cancer patients - Past experience and future directions.Zoledronic acid: an unending tale for an antiresorptive agent.Zoledronic acid use in cancer patients: more than just supportive care?New perspectives on zoledronic acid in breast cancer: potential augmentation of anticancer immune response.Doxycycline inhibits leukemic cell migration via inhibition of matrix metalloproteinases and phosphorylation of focal adhesion kinasePrevention of breast cancer-induced osteolytic bone resorption by benzyl isothiocyanate.
P2860
Q27694500-73F93150-980D-401E-9078-E0CAF82395E0Q33915978-626787ED-71F3-4650-B944-364EE9669EF9Q34613492-9B28945B-BA43-4554-881E-F1C3A0206250Q34998432-B48D6BAA-C438-4E4B-AFE3-987A1D4E00ACQ35964572-C2A11799-B03E-47F2-8AD5-63545F3D84F4Q36337775-BEAB19BD-FA4A-4FA6-BFE8-134BC1BD2238Q36641472-9338C26C-0B3D-4DF7-B8FB-3CC7CF9F546CQ36681335-66944819-FE4E-4504-B4B2-AC1828DC60EBQ37131738-38846EDC-D9AF-44B2-BDD4-4132CCF506FAQ37378228-E71EFBD8-617C-402F-A7C2-4DE29365C751Q37499970-71514834-12FB-4994-810F-AB5E0AD0923CQ37500001-6019AE19-2F2E-41AD-A5E5-61F25277C941Q37650334-64EC90DC-42F9-4555-BF6C-1508D4AF6393Q37828494-D6F4020F-AF72-406B-ACC8-7D954C96D9DBQ37917774-CEE2D4C0-4A56-4AC3-AB54-6EA853F5CA50Q42419112-427734F6-39E8-4FBB-9859-0FFB6B8347C7Q50080460-5E41B350-E540-4434-A6FE-9A37385B3BA3
P2860
Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Effect of zoledronic acid on t ...... model of human breast cancer.
@ast
Effect of zoledronic acid on t ...... model of human breast cancer.
@en
type
label
Effect of zoledronic acid on t ...... model of human breast cancer.
@ast
Effect of zoledronic acid on t ...... model of human breast cancer.
@en
prefLabel
Effect of zoledronic acid on t ...... model of human breast cancer.
@ast
Effect of zoledronic acid on t ...... model of human breast cancer.
@en
P2093
P2860
P356
P1476
Effect of zoledronic acid on t ...... s model of human breast cancer
@en
P2093
S Vukmirović-Popović
W C M Duivenvoorden
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603740
P407
P577
2007-04-17T00:00:00Z